Dr Darryl Maher has had a long career in pharmaceutical product development including over 23 years with CSL Limited. He was vice president of R&D and medical affairs at CSL Behring Australia where he was responsible for the development of multiple drug products from initiation through clinical development and ultimately to commercialisation.
Dr Maher undertook medical training, qualified as a specialist haematologist before commencing his career in the pharmaceutical industry.